Baxter International (BAX) Total Non-Current Liabilities (2009 - 2026)
Baxter International (BAX) reported Total Non-Current Liabilities of $12.5 billion for Q1 2026, down 4.49% year-over-year from $13.1 billion in Q1 2025, and down 1.01% quarter-over-quarter from $12.7 billion in Q4 2025.
Baxter International (BAX) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Baxter International (BAX) has 18 years of Total Non-Current Liabilities data on file, last reported at $12.5 billion in Q1 2026.
- Total Non-Current Liabilities for Q1 2026 came in at $12.5 billion, down 4.49% year-over-year; the trailing twelve-month figure through Mar 2026 was $12.5 billion (down 4.49% YoY), and the FY2025 annual result was $12.7 billion, down 28.37% from the prior year.
- Total Non-Current Liabilities eased to $12.5 billion in Q1 2026 per BAX's latest filing, from $12.7 billion in the prior quarter.
- Over five years, Total Non-Current Liabilities peaked at $21.2 billion in Q1 2022 and troughed at $12.5 billion in Q1 2026.
- A 5-year average of $17.5 billion and a median of $17.9 billion in 2024 frame the typical range for Total Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2025: Total Non-Current Liabilities jumped 126.58% in 2022, then declined 28.37% in 2025.
- A 5-year view of Total Non-Current Liabilities shows it stood at $20.5 billion in 2022, then fell by 10.4% to $18.4 billion in 2023, then slipped by 3.94% to $17.7 billion in 2024, then decreased by 28.37% to $12.7 billion in 2025, then slipped by 1.01% to $12.5 billion in 2026.
- Business Quant data shows BAX's Total Non-Current Liabilities at $12.5 billion in Q1 2026, $12.7 billion in Q4 2025, and $12.7 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 1.91 Bn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | 24.24 Bn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 17.13 Bn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 941.16 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 1.03 Bn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 8.65 Bn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | 3.98 Bn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 2.10 Bn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | 12.54 Bn |
| 10 | Aptargroup | 7.72 Bn | 7.52 Bn | 351.91 Mn | 2.44 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.54 Bn |
| Dec 31, 2025 | 12.67 Bn |
| Sep 30, 2025 | 12.73 Bn |
| Jun 30, 2025 | 12.66 Bn |
| Mar 31, 2025 | 13.13 Bn |
| Dec 31, 2024 | 17.68 Bn |
| Sep 30, 2024 | 17.47 Bn |
| Jun 30, 2024 | 17.01 Bn |
| Mar 31, 2024 | 17.90 Bn |
| Dec 31, 2023 | 18.41 Bn |
| Sep 30, 2023 | 20.71 Bn |
| Jun 30, 2023 | 20.63 Bn |
| Mar 31, 2023 | 20.50 Bn |
| Dec 31, 2022 | 20.54 Bn |
| Sep 30, 2022 | 20.32 Bn |
| Jun 30, 2022 | 20.66 Bn |
| Mar 31, 2022 | 21.16 Bn |
| Dec 31, 2021 | 21.91 Bn |
| Sep 30, 2021 | 9.37 Bn |
| Jun 30, 2021 | 9.52 Bn |